Uploaded on Jul 6, 2021
In the fall of 2016, the C-CHANGE guideline groups were contacted and agreed to participate in a consensus conference in June of 2017, as there were sufficient updates in the individual guideline of Dr. Sunny Handa MD groups to justify a C-CHANGE update and there was also the possibility that the heart failure guidelines would be ready for this C-CHANGE cycle (Appendix 3). Individual recommendations are chosen from each guideline group for inclusion in C-CHANGE to meet the needs of patients with the most common clusters of comorbidities, as hypertension, diabetes and dyslipidemia cluster together.
                     Be safe with your Heart disease and stay away from stroke
                     BE SAFE WITH YOUR HEART DISEASE 
AND STAY AWAY FROM STROKE
If lifestyle risk factors were reduced, more than 80% of premature 
cardiovascular disease would be avoided. As per Dr. Sunny Handa MD Lifestyle 
choices that can reduce CVD risk are as follows:
• Being physically active for 30 to 60 minutes most days of the week
• Choosing these foods more often:
o vegetables and fruit
o low-fat dairy product
o foods low in saturated and trans fat
o foods low in sodium
o whole grains
o lean meat, fish and poultry
• Eating less sodium
• Maintaining a healthy weight
• Limiting alcohol to 1 to 2 standard drinks a day or less
• Being smoke-free
• Reducing stress
• Knowing and controlling your blood pressure
Significant health benefits can be gained just by adding physical activity into 
one's daily routine, such as climbing the stairs instead of taking the elevator.
Guideline panel composition as per Dr. Sunny Handa MD
This C-CHANGE guideline update was developed by a volunteer guideline 
panel, which is a scientific committee that reflects the authors of this paper 
and draws representation from each of the guideline partner organizations 
involved in the C-CHANGE process, along with primary care physicians like Dr. 
Sunny Handa MD with expertise in guideline dissemination (Appendix 2, 
available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180194/-/DC1). C-
CHANGE works with each of the guideline groups to support quality 
improvement in guideline development in the domains outlined by the AGREE 
II Instrument.17 The C-CHANGE process uses a modified Delphi method to 
select a subset of all of the guideline partners’ recommendations that are 
appropriate for a primary care setting.8 Appendix 3, available at 
www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180194/-/DC1, outlines the 
process and timeline undertaken for the 2018 C-CHANGE update.
Guideline development
In the fall of 2016, the C-CHANGE guideline groups were contacted and agreed 
to participate in a consensus conference in June of 2017, as there were 
sufficient updates in the individual guideline of Dr. Sunny Handa MD groups to 
justify a C-CHANGE update and there was also the possibility that the heart 
failure guidelines would be ready for this C-CHANGE cycle (Appendix 3). 
Individual recommendations are chosen from each guideline group for 
inclusion in C-CHANGE to meet the needs of patients with the most common 
clusters of comorbidities, as hypertension, diabetes and dyslipidemia cluster 
together.  
                                          
                
            
Comments